Prelude Growth Partners — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
OneSkin develops skincare products based on its OS-01 Peptide, an ingredient the company says targets cellular senescence to address signs of skin aging.
BiotechConsumerDirect to ConsumerLongevityWellness & FitnessSan Francisco, US
Carolina Reis de Oliveira(Executive Officer, Director)inAlessandra Zonari(Co-founder & Chief Scientific Officer)inCarolina Reis Oliveira(Co-founder & CEO)inAlessandra Zonari Scheel(Founder)inMariana Boroni, PhD(Co-founder)Juliana Carvalho, PhD(Co-founder)
Co-investorsAble PartnersMetaplanetPHD VenturesPLUS CapitalSelva VenturesSOSV+1 more
Perelel makes doctor-formulated vitamin and supplement packs tailored to specific stages of women's hormonal lives, including trying to conceive, pregnancy trimesters, postpartum, motherhood, and perimenopause.
Direct to ConsumerFemTechWellness & FitnessSanta Monica, US
Victoria Thain Gioia(Executive Officer, Director, Promoter)inAlexandra Taylor(Executive Officer, Director, Promoter)Banafsheh Bayati(Co-Founder (board-certified OB/GYN))
BoardRachel Harris(Director)inNeda Daneshzadeh(Director)in
Co-investorsSelva VenturesUnilever VenturesWillow Growth PartnersPRELUDE
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.









